Publications by authors named "W Doss"
Significant research and attention to date have focused on cost-related medication nonadherence as rising prescription drug prices worsen affordability and access for many Americans. This study investigated self-reported sources of medication nonadherence, measuring both cost- and non-cost-related medication nonadherence among community-dwelling Medicare Part D beneficiaries in 2022. A total of 13.
View Article and Find Full Text PDFArticle Synopsis
- The study focuses on evaluating noninvasive methods for assessing liver fibrosis in patients with chronic hepatitis C, comparing six specific serological scores to liver biopsies.
- The research involved a retrospective analysis of data from 19,501 patients, assessing the effectiveness of FIB-4, APRI, King's score, Fibro-Q, fibrosis index, and Fibro-α in diagnosing various stages of liver fibrosis.
- Results showed that four scores, particularly FIB-4 and King's score, demonstrated strong diagnostic performance for identifying advanced fibrosis and cirrhosis, underscoring the importance of noninvasive assessments in resource-limited settings.
Background And Study Aims: Hepatitis C virus (HCV) impairs glucose homoestasis, thus influences its clinical picture and prognosis. This study aimed at evaluating Diabetes mellitus (DM) on Egyptian patients with chronic hepatitis C (CHC), and its impact on their virologic response when treated with directly acting antiviral (DAA) medications.
Patients And Methods: Adult patients with CHC were divided into 2 groups; Diabetic patients, and Non diabetic patients serving as control group.
Background And Study Aims: Hepatitis C virus (HCV) prevalence inchronic kidney disease (CKD) patients is significantly higher than in the general population. This study evaluated the efficacy and safety of combined ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with renal impairment.
Patients And Methods: Our study included 829 patients with normal kidney functions (group 1) and 829 patients with CKD (group 2),which were subdivided into patients not requiring dialysis (group 2a) and those on hemodialysis (group2b).